Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. is projecting substantial growth in client count for Q4 2025, contributing to an expected adjusted operating income margin of approximately 22.4%, which represents an increase of about 270 basis points year-over-year. The company has demonstrated a strong revenue growth of 53.3% alongside a significant expansion of its adjusted operating margin, highlighting improvements in operational efficiency and member outcomes. Additionally, the implementation of the Hinge Connect tool and new programming initiatives are anticipated to drive yields and further enhance the company’s growth trajectory, with penetration rates still below industry norms indicating potential for increased market share.

Bears say

Hinge Health is experiencing a concerning decline in its adjusted R&D expenses as a percentage of revenue, falling from 23.7% in 3Q24 to an anticipated 14.5% in 3Q25, potentially indicating reduced investment in innovation and development. The company's projected EBIT margins are also troubling, with a decline from a 19% EBIT margin in 2Q25 to mid-teens margins in the latter half of 2025, suggesting unsustainable profitability levels as anticipated margins for FY26 and FY27 remain relatively low. Additionally, the management's expectation of a sequential decline in membership and reliance on reduced marketing expenditures during the holiday season raises skepticism regarding the effectiveness of their strategies to enhance revenue growth.

HNGE has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 14 analysts, HNGE has a Buy consensus rating as of Jan 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.